Latest News about EXEL
Recent news which mentions EXEL
   4 Dominant Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
   
  
  
  October 28, 2023
  From Motley Fool
 
   3 Under-the-Radar Biotech Stocks to Buy in 2023
   
  
  
  October 19, 2023
  From Motley Fool
 
   Steady Eddies: 3 Low Beta Stocks for Long-Haul Gains
   
  
  
  October 02, 2023
  From InvestorPlace
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  September 29, 2023
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2023
   
  
  
  September 26, 2023
  From Benzinga
 
   3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
   
  
  
  September 20, 2023
  From InvestorPlace
 
   4 Magnificent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
   
  
  
  September 16, 2023
  From Motley Fool
 
   2 Top Biotech Stocks Defying the Bear Market
   
  
  
  September 15, 2023
  From Motley Fool
 
   The Top Healthcare Stocks to Buy With $100
   
  
  
  August 30, 2023
  From Motley Fool
 
   Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest
   
  
  
  August 24, 2023
  From Benzinga
 
   2 No-Brainer Biotech Stocks to Buy Right Now
   
  
  
  August 24, 2023
  From Motley Fool
 
   These Are the ONLY 3 Biotech Stocks to Consider in August 2023
   
  
  
  August 21, 2023
  From InvestorPlace
 
   Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
   
  
  
  August 21, 2023
  From Benzinga
 
   3 Biotech Stocks You’ll Regret Not Buying Soon
   
  
  
  August 08, 2023
  From InvestorPlace
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
   
  
  
  August 08, 2023
  From Benzinga
 From InvestorPlace
 
   2 Biotech Growth Stocks I'd Buy Right Now
   
  
  
  July 27, 2023
  From Motley Fool
 From InvestorPlace
 
   3 No-Brainer Stocks to Buy With $200 Right Now
   
  
  
  June 21, 2023
  From Motley Fool
 From Motley Fool
 
   2 Under-the-Radar Biotech Stocks to Buy in 2023
   
  
  
  May 24, 2023
  From Motley Fool
 From Motley Fool
 From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
